In mice, subsets of tumor-derived MDSCs expressing PD-1 and CTLA-4 display decreased arginase 1 expression and activity upon CTLA-4 or PD-1 blockade in vitro [173]. This evidence concerns the gene CTLA4 and neoplasm.